Most cases of 'hypergammaglobulinemia (polyclonal gammopathy)' resolve after treatingÂ the primary disease. There is no definitive way of predicting outcomes in an individual patient. However, age, disease group, serum albumin concentration, and platelet count are significant predictors of survival.